Transcode Therapeutics, Inc. SEC filings
Every EDGAR filing for Transcode Therapeutics, Inc. (RNAZ), newest first, with AI summaries and stories.
- Ticker
- RNAZ
- CIK
- 1829635
- Sector
- Biotech and pharma
- Latest filing
- Oct 1
Next: earnings expected ~Oct 26 · 10-Q expected ~Nov 16 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINE3Transcode Therapeutics, Inc.RNAZLIVE John A Tattory, new insider at RNAZ
John A Tattory, reporting
ROUTINE4Transcode Therapeutics, Inc.RNAZLIVE Thomas A Fitzgerald, insider filing for RNAZ
Thomas A Fitzgerald, reporting
ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE NOTABLE10-QTranscode Therapeutics, Inc.RNAZLIVE ROUTINE4Transcode Therapeutics, Inc.RNAZLIVE 2 insider filings
CK Life Sciences Intl (Holdings) Inc, insider filing for RNAZ
Show all 2
- 4Insider filing for RNAZ
- 3New insider at RNAZ
CK Life Sciences Intl (Holdings) Inc, reporting · DEFJ, LLC, reporting
NOTABLESCHEDULE 13D/ATranscode Therapeutics, Inc.RNAZLIVE Ownership stake disclosure by CK Life Sciences Intl (Holdings) Inc (amended)
CK Life Sciences Intl (Holdings) Inc, filed by
ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINESCHEDULE 13GTranscode Therapeutics, Inc.RNAZLIVE 3 13G filings
Ownership stake disclosure by Unleash Immuno Oncolytics, Inc.
Show all 3
- SCHEDULE 13GOwnership stake disclosure
- SCHEDULE 13GOwnership stake disclosure
- SCHEDULE 13GOwnership stake disclosure
Unleash Immuno Oncolytics, Inc., filed by
NOTABLESCHEDULE 13D/ATranscode Therapeutics, Inc.RNAZLIVE Ownership stake disclosure by CK Life Sciences Intl (Holdings) Inc (amended)
CK Life Sciences Intl (Holdings) Inc, filed by
NOTABLESCHEDULE 13D/ATranscode Therapeutics, Inc.RNAZLIVE Ownership stake disclosure by CK Life Sciences Intl (Holdings) Inc (amended)
CK Life Sciences Intl (Holdings) Inc, filed by
ROUTINE424B3Transcode Therapeutics, Inc.RNAZLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B3Securities offering
- 424B3Securities offering
ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE NOTABLESCHEDULE 13D/ATranscode Therapeutics, Inc.RNAZLIVE Ownership stake disclosure by CK Life Sciences Intl (Holdings) Inc (amended)
CK Life Sciences Intl (Holdings) Inc, filed by
ROUTINEDEFA14ATranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINEARSTranscode Therapeutics, Inc.RNAZLIVE ROUTINEDEF 14ATranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINEDEFA14ATranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-K/ATranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINEEFFECTTranscode Therapeutics, Inc.RNAZLIVE ROUTINEEFFECTTranscode Therapeutics, Inc.RNAZLIVE NOTABLE10-QTranscode Therapeutics, Inc.RNAZLIVE ROUTINEPRE 14ATranscode Therapeutics, Inc.RNAZLIVE ROUTINES-3Transcode Therapeutics, Inc.RNAZLIVE ROUTINE10-K/ATranscode Therapeutics, Inc.RNAZLIVE ROUTINESCHEDULE 13GTranscode Therapeutics, Inc.RNAZLIVE Ownership stake disclosure by YA II PN, Ltd.
YA II PN, Ltd., filed by
NOTABLE10-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINEDEFA14ATranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE NOTABLENT 10-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINEDEFA14ATranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINESCHEDULE 13G/ATranscode Therapeutics, Inc.RNAZLIVE Ownership stake disclosure by SABBY MANAGEMENT, LLC (amended)
SABBY MANAGEMENT, LLC, filed by
ROUTINE8-KTranscode Therapeutics, Inc.RNAZLIVE ROUTINE8-K/ATranscode Therapeutics, Inc.RNAZLIVE ROUTINEDEFA14ATranscode Therapeutics, Inc.RNAZLIVE ROUTINEEFFECTTranscode Therapeutics, Inc.RNAZLIVE